Aprea Therapeutics (APRE) Cash & Equivalents (2018 - 2026)
Aprea Therapeutics (APRE) posted Cash & Equivalents of $41.23 million for Q2 2026, up 149.4% from $16.53 million a year earlier but down 11.3% from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Aprea Therapeutics' Cash & Equivalents came in at $14.6 million, down 36.1% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- In prior years, Aprea Therapeutics' Cash & Equivalents was $22.85 million in FY2024 (+5.8%), $21.61 million in FY2023 (-24.9%), $28.79 million in FY2022 (-45.8%) and $53.08 million in FY2021 (-40.4%).
- Quarterly Cash & Equivalents has run from a low of $13.72 million in Q3 2025 to a high of $61.43 million in Q3 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 16.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2026, with growth of 149.4%; the weakest was Q3 2025, with a decline of 47.7%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $46.5 million (Q1 2026), $14.6 million (Q4 2025) and $13.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Aprea Therapeutics | 37.44 Mn | 37.44 Mn | - | 41.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.23 Mn |
| Mar 31, 2026 | 46.50 Mn |
| Dec 31, 2025 | 14.60 Mn |
| Sep 30, 2025 | 13.72 Mn |
| Jun 30, 2025 | 16.53 Mn |
| Mar 31, 2025 | 19.28 Mn |
| Dec 31, 2024 | 22.85 Mn |
| Sep 30, 2024 | 26.25 Mn |
| Jun 30, 2024 | 28.69 Mn |
| Mar 31, 2024 | 32.37 Mn |
| Dec 31, 2023 | 21.61 Mn |
| Sep 30, 2023 | 25.35 Mn |
| Jun 30, 2023 | 27.69 Mn |
| Mar 31, 2023 | 31.00 Mn |
| Dec 31, 2022 | 28.79 Mn |
| Sep 30, 2022 | 33.11 Mn |
| Jun 30, 2022 | 39.06 Mn |
| Mar 31, 2022 | 47.65 Mn |
| Dec 31, 2021 | 53.08 Mn |
| Sep 30, 2021 | 61.43 Mn |
API Access
Aprea Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();